Listen to your vagina.
Ask for BREXAFEMME.
BREXAFEMME is the first and only medicine that actually kills vaginal yeast with one-day oral dosing.
BREXAFEMME is the first and only medicine that actually kills vaginal yeast with one-day oral dosing.
Talk to a healthcare professional about BREXAFEMME
Complete a quick medical form to help your healthcare professional learn more about you.
Schedule an online appointment with a licensed healthcare professional.
Meet with your healthcare professional. If BREXAFEMME is right for you, you can pick it up from your local pharmacy or have it delivered to your home.
YOU ARE NOW LEAVING BREXAFEMME.COM
BREXAFEMME is…
-
different
from all other medicines in how it attacks and kills your vaginal yeast
-
fast
with just one day of oral treatment that won’t disrupt your lifestyle
-
effective
in relieving the uncomfortable symptoms of your vaginal yeast infection
Talk to your doctor to see if BREXAFEMME is right for you.
Not actual size
SO LONG, ITCHY, BURNING YEAST INFECTION
Start feeling better
with BREXAFEMME
Results may vary
DOSING AS EASY AS 1, 2...
well, that’s it!
1-day treatment
Take 2 tablets by
mouth in the morning
Take 2 tablets by
mouth at night
The 2 doses (2 tablets each) should be taken about 12 hours apart. BREXAFEMME can be taken with or without food.
Take BREXAFEMME exactly as your doctor tells you to take it. Tell your healthcare provider about all the medicines you take and all of your medical conditions. Do not take BREXAFEMME if you might be pregnant or plan to become pregnant.
OTHER GOOD STUFF TO KNOW
Patient Information
Get the important details
about BREXAFEMME from the medication
guide, including safety info and more.
Let’s talk
side effects
Treatment with BREXAFEMME during pregnancy can cause harm to your unborn baby. Do not take BREXAFEMME if you are pregnant or plan to become pregnant or are allergic to ibrexafungerp.
Most common side effects include:
- Headache
- Loose stools
- Nausea
- Stomach pain
- Urinary tract infection (UTI)
- Dizziness
- Tiredness (fatigue)
- Vomiting
These are not all the possible side effects of BREXAFEMME.
Before you take BREXAFEMME, tell your healthcare provider about all the medicines you take and your medical conditions, including if you:
- Are breastfeeding or plan to breastfeed. It is not known if BREXAFEMME passes into your breast milk. You and your healthcare provider should decide if you will take BREXAFEMME or breastfeed.
- BREXAFEMME may affect the way other medicines work, and other medicines may affect how BREXAFEMME works. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
DITCH THE ITCH
DITCH THE ITCH.
SAVE ON BREXAFEMME.
Redeem your Savings Card, and you could pay as little as $30
3 ways to get a Savings Card:
- Talk to your doctor about BREXAFEMME and receive a Savings Card
- Visit BREXAFEMME.com/SAVINGS and print the BREXAFEMME Savings Card
- Text “SAVE” to “BREXA” (27392) to instantly receive a mobile Savings Card†
How to redeem your Savings Card:
- Bring your prescription and BREXAFEMME Savings Card to the pharmacy
- Commercially insured patients may pay as little as $30
- Cash-paying patients may pay as little as $175
Want to know more?
Give us a call at
1-844-431-9894.
For terms and conditions, visit BREXAFEMME.com/SAVINGS.
†Message and data rates may apply. 1 message per request. Reply “HELP” for help and “STOP” to stop.
APPROVED USE
BREXAFEMME is a prescription medicine used to treat vaginal yeast infection and reduce the number of recurrent vaginal yeast infections in adults and adolescent females who have started their menstruation.
It is not known if BREXAFEMME is safe and effective in pre-adolescent females who have not started their menstruation.
IMPORTANT SAFETY INFORMATION
BREXAFEMME may cause serious side effects, including:
Harm to your unborn baby. Treatment with BREXAFEMME during pregnancy can cause harm to your unborn baby. Women who can become pregnant may be asked by their healthcare provider to take a pregnancy test before each treatment with BREXAFEMME. Women who can become pregnant should use effective birth control throughout the duration of treatment and for 4 days after the last dose. Talk to your healthcare provider about birth control methods that may be right for you.
If you accidentally receive BREXAFEMME any time while pregnant or within 4 days of getting pregnant, talk to your healthcare provider about taking part in the BREXAFEMME Pregnancy Safety Study. You can participate in this study by calling 1-888-982-7299 or going to
https://www.brexafemmepregnancyregistry.com.
Do not take BREXAFEMME if you:
- Are pregnant or plan to become pregnant. BREXAFEMME may harm your unborn baby. Tell your healthcare provider if you are pregnant, think you might be pregnant, or plan to become pregnant.
- Are allergic to ibrexafungerp.
Before receiving BREXAFEMME, tell your healthcare provider about all the medicines you take and about all your medical conditions, including if you:
- Are breastfeeding or plan to breastfeed. It is not known if BREXAFEMME passes into your breast milk. You and your healthcare provider should decide if you will take BREXAFEMME or breastfeed.
- BREXAFEMME may affect the way other medicines work, and other medicines may affect how BREXAFEMME works. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of BREXAFEMME include
headache, loose stools, nausea, stomach pain, urinary tract infection (UTI), dizziness, tiredness (fatigue), and vomiting.These are not all the possible side effects of BREXAFEMME. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.IBRWCNT230006 July 2023
